DK2964206T3 - Beta-2-adrenerg receptoragonist til forbedring af farvetilpasning af hudar - Google Patents

Beta-2-adrenerg receptoragonist til forbedring af farvetilpasning af hudar Download PDF

Info

Publication number
DK2964206T3
DK2964206T3 DK14716626.8T DK14716626T DK2964206T3 DK 2964206 T3 DK2964206 T3 DK 2964206T3 DK 14716626 T DK14716626 T DK 14716626T DK 2964206 T3 DK2964206 T3 DK 2964206T3
Authority
DK
Denmark
Prior art keywords
adrenerg
beta
receptor agonist
improving skin
skin customization
Prior art date
Application number
DK14716626.8T
Other languages
English (en)
Inventor
Christine Elaine Pullar
Original Assignee
Univ Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leicester filed Critical Univ Leicester
Application granted granted Critical
Publication of DK2964206T3 publication Critical patent/DK2964206T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Biomedical Technology (AREA)
DK14716626.8T 2013-03-08 2014-03-07 Beta-2-adrenerg receptoragonist til forbedring af farvetilpasning af hudar DK2964206T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1304234.6A GB2513297A (en) 2013-03-08 2013-03-08 Methods
PCT/GB2014/050686 WO2014135896A2 (en) 2013-03-08 2014-03-07 Methods

Publications (1)

Publication Number Publication Date
DK2964206T3 true DK2964206T3 (da) 2019-10-07

Family

ID=48189617

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14716626.8T DK2964206T3 (da) 2013-03-08 2014-03-07 Beta-2-adrenerg receptoragonist til forbedring af farvetilpasning af hudar

Country Status (9)

Country Link
US (1) US9943471B2 (da)
EP (1) EP2964206B1 (da)
JP (1) JP6496670B2 (da)
KR (1) KR20150128695A (da)
BR (1) BR112015021668B1 (da)
DK (1) DK2964206T3 (da)
ES (1) ES2748609T3 (da)
GB (1) GB2513297A (da)
WO (1) WO2014135896A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104606177B (zh) * 2014-11-21 2018-02-02 苏州君宁新药开发中心有限公司 左旋(r)沙丁胺醇制剂在治疗皮肤及粘膜创伤溃疡的药物应用
CN110841208B (zh) * 2018-08-21 2023-05-02 魏琳 一种美白祛斑美容仪
JP2023530679A (ja) * 2020-06-11 2023-07-19 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク フェノテロール臭化水素酸塩、β２アドレナリン受容体アゴニスト、及びその誘導体を用いて近視を予防及び治療するための方法及び組成物
CN120053410A (zh) * 2025-01-16 2025-05-30 青岛大学附属医院 普萘洛尔在制备功能性药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740040B1 (fr) 1995-10-23 1997-12-05 Oreal Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p
NZ522882A (en) 2000-06-05 2004-07-30 Altana Pharma Bv Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors
EP1496917B1 (en) 2002-04-19 2005-12-07 Astion Development A/S Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
WO2006027579A2 (en) 2004-09-07 2006-03-16 Sosei R & D Ltd. The treatment of inflammatory disorders and pain
WO2006108176A2 (en) * 2005-04-08 2006-10-12 The Regents Of The University Of California Wound healing composition
CN101203214B (zh) * 2005-04-13 2012-11-21 艾升制药公司 用于治疗皮肤结缔组织疾病的β2-肾上腺素受体激动剂
EP1764081A1 (en) 2005-08-29 2007-03-21 Johnson & Johnson Consumer France SAS Sunscreen composition comprising a dibenzoylmethane, an aminohydroxybenzophenone, a triazine and a triazole as UV filters
JP2009537570A (ja) 2006-05-18 2009-10-29 ティカ レーケメデル アーベー アルブテロールの吸入可能溶液を有する単位用量製剤
MX2010002999A (es) 2007-09-18 2010-06-02 Schering Plough Healthcare Composiciones de proteccion solar con poca irritacion de los ojos y un alto factor de proteccion solar.
GB0724204D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for inhibition of scarring
GB0805535D0 (en) * 2008-03-27 2008-04-30 Univ Leicester Scar prevention
WO2012170695A2 (en) 2011-06-08 2012-12-13 Mary Kay Inc. Sunscreen formulations

Also Published As

Publication number Publication date
KR20150128695A (ko) 2015-11-18
WO2014135896A3 (en) 2014-11-13
JP2016510061A (ja) 2016-04-04
GB2513297A (en) 2014-10-29
BR112015021668A2 (pt) 2017-07-18
EP2964206B1 (en) 2019-07-17
US9943471B2 (en) 2018-04-17
WO2014135896A2 (en) 2014-09-12
EP2964206A2 (en) 2016-01-13
BR112015021668B1 (pt) 2022-03-08
JP6496670B2 (ja) 2019-04-03
ES2748609T3 (es) 2020-03-17
GB201304234D0 (en) 2013-04-24
US20160008247A1 (en) 2016-01-14

Similar Documents

Publication Publication Date Title
DK3083540T3 (da) Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner
DK3848027T3 (da) Octahydro-kondenserede azadecalinglucocorticoidreceptormodulatorer
DK2972353T3 (da) Forbedrede fremgangsmåder til udførelse af multipleksanalyser
PL3024468T3 (pl) Receptory limfocytów T
DK2996556T3 (da) System til billedstyret procedure
DK3545906T3 (da) Indretning til udskiftning af hjerteklap
DK3572105T3 (da) Injektionsindretning til terapeutisk middel
DK3006568T3 (da) Fremgangsmåde til fremstilling af tagatose
BR112015027743A2 (pt) métodos para preparar frações de lignina termicamente estáveis
IL243311A0 (en) Novel antibody frameworks
EP3051933A4 (en) Mounting apparatus
DK3087371T3 (da) Fremgangsmåde til klassificering af frø
DK2992104T3 (da) Fremgangsmåde til ekspression
LT3068800T (lt) Fcrn receptoriui specifiniai antikūnai
DK2837678T3 (da) Fremgangsmåde til forbedret afsmeltning
DK2951552T3 (da) Opfangningsanordning til engangsbrug
DK3066228T3 (da) Fremgangsmåde til opnåelse af fotokatalytisk materiale
DK3047025T3 (da) Fremgangsmåde til fremstilling af kappevira
DK2964206T3 (da) Beta-2-adrenerg receptoragonist til forbedring af farvetilpasning af hudar
DK3080447T3 (da) Rotorvingeafladningsenhed til vindmøller
EP2986733A4 (en) G-PROTEIN-COUPLED RECEPTOR LIBRARIES
DK3074384T3 (da) Amidderivater til gpr119-agonist
IL243730A0 (en) Vasopressin-2 receptor agonists
GB201312010D0 (en) Receptor Agonists
UA27816S (uk) Кріплення для лиж